Research collaboration opportunities

We have a successful record of research collaborations, in areas such as oncology, with partners including Novartis (now advanced into Phase II clinical studies), Servier, GSK and Lundbeck. Vernalis’ structure and fragment-based drug discovery expertise is available to support a variety of target-specific collaborations.

We continue to seek further research collaborations. Contact us to discuss our particular research expertise, with a view to possible joint research projects. Contact us >

See our current collaborations >

Latest News